Interferon alpha (IFNα) belongs to type I IFN, which is the first remedy approved for the treatment of chronic hepatitis B and can achieve sustained virological response in a minority of patients, with significant side effects (15). The gene discussed is IFNA2; the disease is chronic hepatitis B virus infection.